129 related articles for article (PubMed ID: 17545606)
1. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma.
Das AK; Chen BP; Story MD; Sato M; Minna JD; Chen DJ; Nirodi CS
Cancer Res; 2007 Jun; 67(11):5267-74. PubMed ID: 17545606
[TBL] [Abstract][Full Text] [Related]
2. Targeting HER3-dependent activation of nuclear AKT improves radiotherapy of non-small cell lung cancer.
Toulany M; Iida M; Lettau K; Coan JP; Rebholz S; Khozooei S; Harari PM; Wheeler DL
Radiother Oncol; 2022 Sep; 174():92-100. PubMed ID: 35839938
[TBL] [Abstract][Full Text] [Related]
3. Silencing UCHL3 enhances radio-sensitivity of non-small cell lung cancer cells by inhibiting DNA repair.
Liu M; Chen H; Chen X; Xiong J; Song Z
Aging (Albany NY); 2021 May; 13(10):14277-14288. PubMed ID: 34016790
[TBL] [Abstract][Full Text] [Related]
4. Importance of EGFR/ERCC1 interaction following radiation-induced DNA damage.
Liccardi G; Hartley JA; Hochhauser D
Clin Cancer Res; 2014 Jul; 20(13):3496-506. PubMed ID: 24780295
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells.
Ali M; Lu M; Ang HX; Soderquist RS; Eyler CE; Hutchinson HM; Glass C; Bassil CF; Lopez OM; Kerr DL; Falcon CJ; Yu HA; Hata AN; Blakely CM; McCoach CE; Bivona TG; Wood KC
Sci Transl Med; 2022 Mar; 14(638):eabc7480. PubMed ID: 35353542
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of demethylase by IOX1 modulates chromatin accessibility to enhance NSCLC radiation sensitivity through attenuated PIF1.
Li Q; Qin K; Tian Y; Chen B; Zhao G; Xu S; Wu L
Cell Death Dis; 2023 Dec; 14(12):817. PubMed ID: 38086789
[TBL] [Abstract][Full Text] [Related]
7. Differences in Radiosensitivity According to EGFR Mutation Status in Non-Small Cell Lung Cancer: A Clinical and In Vitro Study.
Tanaka H; Karita M; Ueda K; Ono T; Kajima M; Manabe Y; Fujimoto K; Yuasa Y; Shiinoki T
J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38248726
[TBL] [Abstract][Full Text] [Related]
8. Genome-scale CRISPR-Cas9 screen identifies
Li Y; Zhu L; Mao J; Zheng H; Hu Z; Yang S; Mao T; Zhou T; Cao P; Wu H; Wang X; Wang J; Lin F; Shen H
MedComm (2020); 2024 Mar; 5(3):e483. PubMed ID: 38463398
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinase.
Brognard J; Zhang YW; Puto LA; Hunter T
Cancer Res; 2011 Apr; 71(8):3152-61. PubMed ID: 21487036
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the base excision repair NTHL1 glycosylase causes genomic instability and early cellular hallmarks of cancer.
Limpose KL; Trego KS; Li Z; Leung SW; Sarker AH; Shah JA; Ramalingam SS; Werner EM; Dynan WS; Cooper PK; Corbett AH; Doetsch PW
Nucleic Acids Res; 2018 May; 46(9):4515-4532. PubMed ID: 29522130
[TBL] [Abstract][Full Text] [Related]
11. Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer.
Willers H; Azzoli CG; Santivasi WL; Xia F
Cancer J; 2013; 19(3):200-7. PubMed ID: 23708066
[TBL] [Abstract][Full Text] [Related]
12. Non-canonical signaling mode of the epidermal growth factor receptor family.
Lee HH; Wang YN; Hung MC
Am J Cancer Res; 2015; 5(10):2944-58. PubMed ID: 26693051
[TBL] [Abstract][Full Text] [Related]
13. EGFR Mutations Compromise Hypoxia-Associated Radiation Resistance through Impaired Replication Fork-Associated DNA Damage Repair.
Saki M; Makino H; Javvadi P; Tomimatsu N; Ding LH; Clark JE; Gavin E; Takeda K; Andrews J; Saha D; Story MD; Burma S; Nirodi CS
Mol Cancer Res; 2017 Nov; 15(11):1503-1516. PubMed ID: 28801308
[TBL] [Abstract][Full Text] [Related]
14. EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.
Liccardi G; Hartley JA; Hochhauser D
Cancer Res; 2011 Feb; 71(3):1103-14. PubMed ID: 21266349
[TBL] [Abstract][Full Text] [Related]
15. Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma.
Haga Y; Sakamoto Y; Kajiya K; Kawai H; Oka M; Motoi N; Shirasawa M; Yotsukura M; Watanabe SI; Arai M; Zenkoh J; Shiraishi K; Seki M; Kanai A; Shiraishi Y; Yatabe Y; Matsubara D; Suzuki Y; Noguchi M; Kohno T; Suzuki A
Nat Commun; 2023 Dec; 14(1):8375. PubMed ID: 38102134
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy.
Oyoshi H; Hirata H; Hirano Y; Zenda S; Zhou Y; Tomizawa K; Fujisawa T; Nakamura M; Hojo H; Motegi A; Kageyama SI; Zenke Y; Goto K; Ishihara S; Naganawa S; Akimoto T
Clin Exp Metastasis; 2023 Oct; 40(5):407-413. PubMed ID: 37468822
[TBL] [Abstract][Full Text] [Related]
17. DNA-PK is activated by SIRT2 deacetylation to promote DNA double-strand break repair by non-homologous end joining.
Head PE; Kapoor-Vazirani P; Nagaraju GP; Zhang H; Rath SK; Luong NC; Haji-Seyed-Javadi R; Sesay F; Wang SY; Duong DM; Daddacha W; Minten EV; Song B; Danelia D; Liu X; Li S; Ortlund EA; Seyfried NT; Smalley DM; Wang Y; Deng X; Dynan WS; El-Rayes B; Davis AJ; Yu DS
Nucleic Acids Res; 2023 Aug; 51(15):7972-7987. PubMed ID: 37395399
[TBL] [Abstract][Full Text] [Related]
18. Survival benefit of thoracic radiotherapy plus EGFR-TKIs in patients with non-oligometastatic advanced non-small-cell lung cancer: a single-center retrospective study.
Zhou F; Qin Y; Liu X; Huang J; Wu B; Zhang Z; Yin Z; Yang J; Zhang S; Jiang K; Yang K
Ther Adv Med Oncol; 2023; 15():17588359231161411. PubMed ID: 36970112
[TBL] [Abstract][Full Text] [Related]
19. Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer.
Zhou T; Zhang LY; He JZ; Miao ZM; Li YY; Zhang YM; Liu ZW; Zhang SZ; Chen Y; Zhou GC; Liu YQ
Front Immunol; 2023; 14():1133899. PubMed ID: 36865554
[TBL] [Abstract][Full Text] [Related]
20. Association Between
Sit D; Bale M; Lapointe V; Olson R; Hsu F
JTO Clin Res Rep; 2022 Aug; 3(8):100371. PubMed ID: 35941996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
